In PI3K inhibitor resistant breast cancer cells, substantial metabolic rewiring occurs following removal of the class IA PI3K inhibitor GDC-0941 that is characterized by increased glycolysis and mitochondrial respiration (98). This evidence concerns the gene PIK3CA and breast carcinoma.